Abstract
The underlying genetic causes and altered signaling pathways of brain arteriovenous malformations remain unknown. A study published in The New England Journal of Medicine reported that KRAS somatic mutations (p.Gly12Val/Asp) were identified in brain arteriovenous malformations of human subjects and endothelial cell-enriched cultures, which might specifically activate the MAPK (mitogen-activated protein kinase)–ERK (extracellular signal-regulated kinase) signaling pathway in brain endothelial cells.
Original language | English |
---|---|
Pages (from-to) | 481-483 |
Number of pages | 3 |
Journal | Trends in Biochemical Sciences |
Volume | 43 |
Issue number | 7 |
DOIs | |
State | Published - Jul 2018 |
Keywords
- KRAS
- KRAS4A
- brain arteriovenous malformations
- endothelial cells
- somatic mutation